Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention

Contrast-induced acute kidney injury (CI-AKI) is a serious complication of diagnostic coronary angiograph and percutaneous coronary intervention (PCI). However, the exact pathophysiological mechanisms underlying CI-AKI development are largely unknown. The present study examined whether urinary semap...

Full description

Bibliographic Details
Main Authors: Li Ning, Zhiguo Li, Dianjun Wei, Haiyan Chen, Chao Yang, Dawei Wu, Yanchun Wang, Jingwei Zhang
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2018-03-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000400618&lng=en&tlng=en
_version_ 1819044700868313088
author Li Ning
Zhiguo Li
Dianjun Wei
Haiyan Chen
Chao Yang
Dawei Wu
Yanchun Wang
Jingwei Zhang
author_facet Li Ning
Zhiguo Li
Dianjun Wei
Haiyan Chen
Chao Yang
Dawei Wu
Yanchun Wang
Jingwei Zhang
author_sort Li Ning
collection DOAJ
description Contrast-induced acute kidney injury (CI-AKI) is a serious complication of diagnostic coronary angiograph and percutaneous coronary intervention (PCI). However, the exact pathophysiological mechanisms underlying CI-AKI development are largely unknown. The present study examined whether urinary semaphorin 3A levels predict the development of CI-AKI in patients undergoing PCI. This study enrolled 168 patients with stable angina undergoing elective PCI. Serial urine samples, obtained at baseline and 2, 6, 12, 24, 36, and 48 h post-PCI were analyzed by semaphorin 3A and neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. AKI was defined as an increase in serum creatinine beyond 50% according to the RIFLE classification system. Receiver operator characteristic (ROC) curve analyses identified optimal semaphorin 3A and NGAL values for diagnosing CI-AKI. CI-AKI occurred in 20 of 168 patients. There were no significant differences in the baseline clinical characteristics and angiographic findings between non-AKI patients group and AKI patients group. Both urinary semaphorin 3A and NGAL levels significantly increased at 2 and 6 h post-PCI. ROC analysis showed that the cut-off value of 389.5 pg/mg semaphorin 3A at 2 h post-PCI corresponds to 94% sensitivity and 75% specificity and the cut-off value of 94.4 ng/mg NGAL at 2 h post-PCI corresponds to 74% sensitivity and 82% specificity. Logistic regression showed that semaphorin 3A levels at 2 and 6 h post-PCI were the significant predictors of AKI in our cohort. Urinary semaphorin 3A may be a promising early biomarker for predicting CI-AKI in patients undergoing PCI.
first_indexed 2024-12-21T10:16:51Z
format Article
id doaj.art-1d85de3d4a164f2f9a37752287af9291
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-12-21T10:16:51Z
publishDate 2018-03-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-1d85de3d4a164f2f9a37752287af92912022-12-21T19:07:33ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2018-03-0151410.1590/1414-431x20176487S0100-879X2018000400618Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventionLi NingZhiguo LiDianjun WeiHaiyan ChenChao YangDawei WuYanchun WangJingwei ZhangContrast-induced acute kidney injury (CI-AKI) is a serious complication of diagnostic coronary angiograph and percutaneous coronary intervention (PCI). However, the exact pathophysiological mechanisms underlying CI-AKI development are largely unknown. The present study examined whether urinary semaphorin 3A levels predict the development of CI-AKI in patients undergoing PCI. This study enrolled 168 patients with stable angina undergoing elective PCI. Serial urine samples, obtained at baseline and 2, 6, 12, 24, 36, and 48 h post-PCI were analyzed by semaphorin 3A and neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. AKI was defined as an increase in serum creatinine beyond 50% according to the RIFLE classification system. Receiver operator characteristic (ROC) curve analyses identified optimal semaphorin 3A and NGAL values for diagnosing CI-AKI. CI-AKI occurred in 20 of 168 patients. There were no significant differences in the baseline clinical characteristics and angiographic findings between non-AKI patients group and AKI patients group. Both urinary semaphorin 3A and NGAL levels significantly increased at 2 and 6 h post-PCI. ROC analysis showed that the cut-off value of 389.5 pg/mg semaphorin 3A at 2 h post-PCI corresponds to 94% sensitivity and 75% specificity and the cut-off value of 94.4 ng/mg NGAL at 2 h post-PCI corresponds to 74% sensitivity and 82% specificity. Logistic regression showed that semaphorin 3A levels at 2 and 6 h post-PCI were the significant predictors of AKI in our cohort. Urinary semaphorin 3A may be a promising early biomarker for predicting CI-AKI in patients undergoing PCI.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000400618&lng=en&tlng=enContrast-induced acute kidney injuryPercutaneous coronary interventionSemaphorin 3ANeutrophil gelatinase-associated lipocalinBiomarker
spellingShingle Li Ning
Zhiguo Li
Dianjun Wei
Haiyan Chen
Chao Yang
Dawei Wu
Yanchun Wang
Jingwei Zhang
Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
Brazilian Journal of Medical and Biological Research
Contrast-induced acute kidney injury
Percutaneous coronary intervention
Semaphorin 3A
Neutrophil gelatinase-associated lipocalin
Biomarker
title Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
title_full Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
title_fullStr Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
title_full_unstemmed Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
title_short Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
title_sort urinary semaphorin 3a as an early biomarker to predict contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention
topic Contrast-induced acute kidney injury
Percutaneous coronary intervention
Semaphorin 3A
Neutrophil gelatinase-associated lipocalin
Biomarker
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000400618&lng=en&tlng=en
work_keys_str_mv AT lining urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT zhiguoli urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT dianjunwei urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT haiyanchen urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT chaoyang urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT daweiwu urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT yanchunwang urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention
AT jingweizhang urinarysemaphorin3aasanearlybiomarkertopredictcontrastinducedacutekidneyinjuryinpatientsundergoingpercutaneouscoronaryintervention